Navco Pharmaceuticals (FRA:F0U) DeferredTaxAndRevenue: €0.00 Mil (As of Mar. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Navco Pharmaceuticals DeferredTaxAndRevenue?

Navco Pharmaceuticals FRA:F0U DeferredTaxAndRevenue is €0.00 Mil as of Mar. 2023.

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Navco Pharmaceuticals's current deferred tax and revenue for the quarter that ended in Mar. 2023 was €0.00 Mil.

Navco Pharmaceuticals DeferredTaxAndRevenue Related Terms

Navco Pharmaceuticals DeferredTaxAndRevenue Historical Data

* Premium members only.

The historical data trend for Navco Pharmaceuticals's DeferredTaxAndRevenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Navco Pharmaceuticals DeferredTaxAndRevenue Chart

Navco Pharmaceuticals Annual Data
Trend Jun18 Jun19 Jun20 Jun21
DeferredTaxAndRevenue
0.00 0.00 0.00 0.00

Navco Pharmaceuticals Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
DeferredTaxAndRevenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
Frequently Asked Questions Learn more about DeferredTaxAndRevenue →
What does a DeferredTaxAndRevenue of €0.00 Mil mean?
Navco Pharmaceuticals (FRA:F0U) has a DeferredTaxAndRevenue of €0.00 Mil as of Mar. 2023. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on Navco Pharmaceuticals.
Is Navco Pharmaceuticals' DeferredTaxAndRevenue too high?
Navco Pharmaceuticals' current DeferredTaxAndRevenue is €0.00 Mil.
How does Navco Pharmaceuticals' DeferredTaxAndRevenue compare to ZTS and VTRS?
Navco Pharmaceuticals' DeferredTaxAndRevenue of €0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good DeferredTaxAndRevenue for a Drug Manufacturers company?
A good DeferredTaxAndRevenue depends on the Drug Manufacturers industry context. However, DeferredTaxAndRevenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high DeferredTaxAndRevenue mean?
A high DeferredTaxAndRevenue can signal that a stock is expensive relative to its fundamentals. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on Navco Pharmaceuticals. Navco Pharmaceuticals's current DeferredTaxAndRevenue is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Navco Pharmaceuticals stock overvalued right now?
Navco Pharmaceuticals (FRA:F0U) has a current DeferredTaxAndRevenue of €0.00 Mil. The current DeferredTaxAndRevenue is €0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is DeferredTaxAndRevenue calculated?
DeferredTaxAndRevenue is calculated from a company's financial statements. For Navco Pharmaceuticals (FRA:F0U), the current DeferredTaxAndRevenue is €0.00 Mil as of Mar. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Navco Pharmaceuticals Business Description

Address 1055 West Georgia Street, Suite 1500, Vancouver, BC, CAN, V6E 4N7
Navco Pharmaceuticals Inc is engaged in creating nanotechnology products using computer algorithms. The products are used in various industries like medicine, textiles, chemicals, and additives to combat microorganisms such as viruses and bacteria. Its products include aerosol sprays, hand cleansers, hand creams, and nano BioGuard(tm)-Silver.